Why the study?
Does emergent PTCA and stent placement result in a successful outcome for STEMI during the third trimester of pregnancy?
Does emergent PTCA and stent placement result in a successful outcome for STEMI during the third trimester of pregnancy?
PTCA with stent placement can be successfully used to treat STEMI during the third trimester of pregnancy.
In Brief BACKGROUND: Myocardial infarction (MI) is uncommon during pregnancy. As the average maternal age increases and assisted reproductive technology allows for very advanced maternal ages, so too may the incidence of MI during pregnancy. Percutaneous transluminal coronary angioplasty (PTCA) with stent placement is an attractive option for treatment of MI in pregnancy when revascularization is required. CASE: We present a gravida with an ST elevation MI during the third trimester, who was treated with emergent PTCA, stent placement, and platelet inhibitors, and we discuss the patient’s subsequent obstetric and anesthetic management. CONCLUSION: Percutaneous transluminal coronary angioplasty with stent placement may be used during the third trimester with successful outcome. ST elevation myocardial infarction during pregnancy may be treated successfully with percutaneous transluminal coronary angioplasty and stent placement.
No takes yet. Share an insight, caveat, or question.
Dwyer et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: